Select Category

New treatment for Lupus (SLE). Dr. Humeira Badsha

Go Back

Posted on by

Benlysta (belimumab) was approved on March 9, 2011 by the FDA for the treatment of active, autoantibody-positive lupus in patients who are receiving standard therapy including corticosteroids,antimalarials, immunosuppressives, and NSAIDs (nonsteroidal anti-inflammatory drugs). Benlysta is administered as an intravenous infusion (through an I.V.). It is the first drug designed to target B-lymphocyte stimulator (BLyS) protein. This action should decrease the number of abnormal B cells which are thought to be problematic in lupus.

It’s fair to say, the approval of Benlysta has been watched and anticipated by lupus patients and anyone with an interest in lupus. It has been 56 years since a new drug was approved for lupus. Plaquenil and corticosteroids were approved for lupus back in 1955.

Two clinical trials involving 1,684 lupus patients concluded that Benlysta was safe and effective. The studies randomly assigned patients with active lupus to receive Benlysta along with standard lupus therapy, or placebo along with standard therapy. Patients receiving Benlysta and standard therapy had less disease activity than the placebo group. African Americans did not seem to respond well to Benlysta in the studies. Further studies are needed so researchers can formulate a conclusion regarding African Americans and Benlysta. For more Benlysta information, check out the FDA news about the approval.

It is still early to say who should receive this treatment and how. Is it going to be used for the most severe cases or for anyone with active SLE? We are awaiting this medication eagerly in the UAE and will be posting here as soon as it becomes available.

About Arthritis Center

This web site is run by an Arthritis Specialist based in Dubai, United Arab Emirates. On this site you will find news about the latest in arthritis, information about research results in the field, tips and information and diet and exercise, and much more.

More

Archives


Latest Blog

Using your genes to predict if you will respond to Rheumatoid arthritis therapy. (not available in Dubai, UAE at this time)

The ORBIT data “showed that patients who have seropositive rheumatoid arthritis are just as likely to respond to rituximab therapy when compared ...

Read More

Your nose can repair your knee arthritis? Not yet in Dubai!

Doctors might one day be able to harvest cells from patients’ noses to produce cartilage that can be transplanted into damaged knee joints, a sma...

Read More

Green tea to the rescue!

Green tea has always been hailed for its anti-inflammatory properties. But researchers at Washington State University (WSU) in Spokane have now ide...

Read More

This web site is run by an Arthritis Specialist based in Dubai, United Arab Emirates. On this site you will find news about the latest in arthritis, information about research results in the field, tips and information and diet and exercise, and much more.

More

Recent Comments